| Kjeldsen R, Sandbæk A
[Exenatide as an alternative to insulin in the treatment of type 2 diabetes.] [JOURNAL ARTICLE]
Ugeskr Laeger 2008 Sep 22; 170(39):3039-3043.
Abstract | Full Citation |
| Kittisupamongkol W
Effect of folic acid and B vitamins on cardiovascular disease in women. [Comment, Letter]
JAMA 2008 Sep 24; 300(12):1410; author reply 1410.
Full Citation | Publisher Full Text | Find Related Articles |
| Gebel E
Embracing insulin. It's a miracle drug. So why do so many people with type 2 try to avoid the needle at any cost? [Journal Article]
Diabetes Forecast 2008 Aug; 61(8):45-7.
Full Citation | Find Related Articles |
| Høibraaten E, Folkersen J
[In Process Citation] [Journal Article]
Tidsskr Nor Laegeforen 2008 Sep 11; 128(17):1985.
Full Citation | Publisher Full Text |
| Goldfine AB
Assessing the cardiovascular safety of diabetes therapies. [Journal Article]
N Engl J Med 2008 Sep 11; 359(11):1092-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Nichols GA, Brown JB
Validating the Framingham Offspring Study equations for predicting incident diabetes mellitus. [Journal Article]
Am J Manag Care 2008 Sep; 14(9):574-80.
Abstract | Full Citation | Find Related Articles |
| Matthews DR, Tsapas A
Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes. [Journal Article]
Diab Vasc Dis Res 2008 Sep; 5(3):216-8.
Full Citation | Find Related Articles |
| Katakami N, Matsuhisa M, Kaneto H, et al.
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients. [Journal Article]
Diab Vasc Dis Res 2008 Sep; 5(3):190-7.
Abstract | Full Citation | Find Related Articles |
| Saleem T, Mohammad KH, Abdel-Fattah MM, et al.
Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. [Journal Article]
Diab Vasc Dis Res 2008 Sep; 5(3):184-9.
Abstract | Full Citation | Find Related Articles |
| Rubin CJ, Ledeine JM, Fiedorek FT
Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride. [Journal Article]
Diab Vasc Dis Res 2008 Sep; 5(3):168-76.
Abstract | Full Citation |
  |
